<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d224">
    <sentence id="DDI-DrugBank.d224.s0" text="Apraclonidine should not be used in patients receiving MAO inhibitors..">
        <entity id="DDI-DrugBank.d224.s0.e0" charOffset="0-12"
            type="drug" text="Apraclonidine"/>
        <entity id="DDI-DrugBank.d224.s0.e1" charOffset="55-68"
            type="group" text="MAO inhibitors"/>
        <ddi id="DDI-DrugBank.d224.s0.d0" e1="DDI-DrugBank.d224.s0.e0"
            e2="DDI-DrugBank.d224.s0.e1" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s1" text="Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, anesthetics) should be considered.">
        <entity id="DDI-DrugBank.d224.s1.e0" charOffset="130-137"
            type="brand" text="IOPIDINE"/>
        <entity id="DDI-DrugBank.d224.s1.e1" charOffset="224-238"
            type="group" text="CNS depressants"/>
        <entity id="DDI-DrugBank.d224.s1.e2" charOffset="241-247"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d224.s1.e3" charOffset="250-261"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d224.s1.e4" charOffset="264-270"
            type="group" text="opiates"/>
        <entity id="DDI-DrugBank.d224.s1.e5" charOffset="273-281"
            type="group" text="sedatives"/>
        <entity id="DDI-DrugBank.d224.s1.e6" charOffset="284-294"
            type="group" text="anesthetics"/>
        <ddi id="DDI-DrugBank.d224.s1.d0" e1="DDI-DrugBank.d224.s1.e0"
            e2="DDI-DrugBank.d224.s1.e1" type="advise"/>
        <ddi id="DDI-DrugBank.d224.s1.d1" e1="DDI-DrugBank.d224.s1.e0"
            e2="DDI-DrugBank.d224.s1.e2" type="advise"/>
        <ddi id="DDI-DrugBank.d224.s1.d2" e1="DDI-DrugBank.d224.s1.e0"
            e2="DDI-DrugBank.d224.s1.e3" type="advise"/>
        <ddi id="DDI-DrugBank.d224.s1.d3" e1="DDI-DrugBank.d224.s1.e0"
            e2="DDI-DrugBank.d224.s1.e4" type="advise"/>
        <ddi id="DDI-DrugBank.d224.s1.d4" e1="DDI-DrugBank.d224.s1.e0"
            e2="DDI-DrugBank.d224.s1.e5" type="advise"/>
        <ddi id="DDI-DrugBank.d224.s1.d5" e1="DDI-DrugBank.d224.s1.e0"
            e2="DDI-DrugBank.d224.s1.e6" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s2" text="Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.">
        <entity id="DDI-DrugBank.d224.s2.e0" charOffset="0-24"
            type="group" text="Tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d224.s2.e1" charOffset="89-97"
            type="drug" text="clonidine"/>
        <ddi id="DDI-DrugBank.d224.s2.d0" e1="DDI-DrugBank.d224.s2.e0"
            e2="DDI-DrugBank.d224.s2.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s3" text="It is not known whether the concurrent use of these agents with apraclonidine can lead to a reduction in IOP lowering effect.">
        <entity id="DDI-DrugBank.d224.s3.e0" charOffset="64-76"
            type="drug" text="apraclonidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s4" text="No data on the level of circulating catecholamines after apraclonidine withdrawal are available.">
        <entity id="DDI-DrugBank.d224.s4.e0" charOffset="57-69"
            type="drug" text="apraclonidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s5" text="Caution, however, is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines.">
        <entity id="DDI-DrugBank.d224.s5.e0" charOffset="48-72"
            type="group" text="tricyclic antidepressants"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s6" text="An additive hypotensive effect has been reported with the combination of systemic clonidine and neuroleptic therapy.">
        <entity id="DDI-DrugBank.d224.s6.e0" charOffset="82-90"
            type="drug" text="clonidine"/>
        <entity id="DDI-DrugBank.d224.s6.e1" charOffset="96-106"
            type="group" text="neuroleptic"/>
        <ddi id="DDI-DrugBank.d224.s6.d0" e1="DDI-DrugBank.d224.s6.e0"
            e2="DDI-DrugBank.d224.s6.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s7" text="Systemic clonidine may inhibit the production of catecholamines in response to insulin-induced hypoglycemia and mask the signs and symptoms of hypoglycemia.">
        <entity id="DDI-DrugBank.d224.s7.e0" charOffset="9-17"
            type="drug" text="clonidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s8" text="Since apraclonidine may reduce pulse and blood pressure, caution in using drugs such as beta-blockers (ophthalmic and systemic), antihypertensives, and cardiac glycosides is advised.">
        <entity id="DDI-DrugBank.d224.s8.e0" charOffset="6-18"
            type="drug" text="apraclonidine"/>
        <entity id="DDI-DrugBank.d224.s8.e1" charOffset="88-100"
            type="group" text="beta-blockers"/>
        <entity id="DDI-DrugBank.d224.s8.e2" charOffset="129-145"
            type="group" text="antihypertensives"/>
        <entity id="DDI-DrugBank.d224.s8.e3" charOffset="152-169"
            type="group" text="cardiac glycosides"/>
        <ddi id="DDI-DrugBank.d224.s8.d0" e1="DDI-DrugBank.d224.s8.e0"
            e2="DDI-DrugBank.d224.s8.e1" type="advise"/>
        <ddi id="DDI-DrugBank.d224.s8.d1" e1="DDI-DrugBank.d224.s8.e0"
            e2="DDI-DrugBank.d224.s8.e2" type="advise"/>
        <ddi id="DDI-DrugBank.d224.s8.d2" e1="DDI-DrugBank.d224.s8.e0"
            e2="DDI-DrugBank.d224.s8.e3" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s9" text="Patients using cardiovascular drugs concurrently with IOPIDINE 0.5% Ophthalmic Solution should have pulse and blood pressures frequently monitored.">
        <entity id="DDI-DrugBank.d224.s9.e0" charOffset="54-61"
            type="brand" text="IOPIDINE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s10" text="Caution should be exercised with simultaneous use of clonidine and other similar pharmacologic agents">
        <entity id="DDI-DrugBank.d224.s10.e0" charOffset="53-61"
            type="drug" text="clonidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d224.s11" text="."/>
    <sentence id="DDI-DrugBank.d224.s12" text=""/>
</document>
